✦ LIBER ✦

Clinical trial of immunotherapy with paternal mononuclear cells for unexplained recurrent miscarriage

✍ Scribed by F.A. Saad; A. Al-Hilali

Book ID: 117123502
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 155 KB
Volume: 70
Category: Article
ISSN: 0020-7292
DOI: 10.1016/s0020-7292(00)81507-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical evaluation of immunotherapy in

Clinical evaluation of immunotherapy in early pregnancy with x-irradiated paternal mononuclear cells for primary recurrent aborters

✍ K. Aoki; S. Kajiura; Y. Matsumoto; Y. Yagami 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Alteration of TH1 and TH2 cells by intra

Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband’s mononuclear cells

✍ Tomokazu Yokoo; Koichi Takakuwa; Izumi Ooki; Akira Kikuchi; Masaki Tamura; Kenic 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 187 KB

15A Paternal cell immunization for recur

15A Paternal cell immunization for recurrent miscarriage: A comparison of meta-analyses with and without individual patient data

✍ Gary T. Jeng; James R. Scott; Leon Burmeister 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Granulocyte-macrophage–colony stimulatin

Granulocyte-macrophage–colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma : Results of two Phase II clinical trials

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Mary C. Dumas; Timothy Kuzel; Walter 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The aim of this study was to determine the response rates and toxicity of two regimens containing granulocyte-macrophage-colony stimulating factor (GM-CSF) in combination with interleukin-2 (IL-2) in the treatment of patients with metastatic renal cell carcinoma. ## METHODS. Therapy given in the f

A phase I/IIa clinical trial of immunoth

A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate

✍ Toshio Kitawaki; Norimitsu Kadowaki; Keiko Fukunaga; Yasunari Kasai; Taira Maeka 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Immune monitoring with iTAg™ MHC tetrame

Immune monitoring with iTAg™ MHC tetramers for prediction of recurrent or persistent cytomegalovirus (CMV) infection in allogeneic stem cell transplant (SCT) recipients: A prospective multicenter clinical trial

✍ M. Boeckh; R. Nakamura; J.J. Cornelissen; J.A. Zaia; S.J. Forman; K. Gaal; R.A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 72 KB